Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Chimerix Inc (CMRX)

Chimerix Inc (CMRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 106,191
  • Shares Outstanding, K 61,382
  • Annual Sales, $ 7,220 K
  • Annual Income, $ -69,470 K
  • 60-Month Beta 1.55
  • Price/Sales 8.61
  • Price/Cash Flow N/A
  • Price/Book 0.95

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.17
  • Number of Estimates 2
  • High Estimate -0.15
  • Low Estimate -0.19
  • Prior Year -0.29
  • Growth Rate Est. (year over year) +41.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.62 +7.12%
on 01/31/20
2.10 -17.42%
on 01/22/20
-0.35 (-16.83%)
since 01/21/20
3-Month
1.62 +7.12%
on 01/31/20
2.86 -39.51%
on 12/03/19
-0.29 (-14.36%)
since 11/21/19
52-Week
1.25 +38.40%
on 10/25/19
4.40 -60.68%
on 07/01/19
-0.19 (-9.90%)
since 02/21/19

Most Recent Stories

More News
Chimerix to Report Fourth Quarter and Year End 2019 Financial Results and Provide an Operational Update on February 25, 2020

Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announced that it will host a live conference...

CMRX : 1.73 (unch)
Chimerix Presents Data Supporting Brincidofovir as a Potential Treatment for Smallpox at 2020 American Society for Microbiology Biothreats Meeting

Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announces that data in support of brincidofovir...

CMRX : 1.73 (unch)
Has Chimerix (CMRX) Outpaced Other Medical Stocks This Year?

Is (CMRX) Outperforming Other Medical Stocks This Year?

CMRX : 1.73 (unch)
New Trade Deal, New Records for S&P and NASDAQ

New Trade Deal, New Records for S&P and NASDAQ

MTDR : 12.64 (-2.84%)
VICI : 28.15 (+0.07%)
COST : 321.95 (-0.66%)
VRA : 9.23 (-3.85%)
NTCT : 29.59 (+0.71%)
ROKU : 119.38 (-3.79%)
CCC : 22.92 (-0.87%)
OLED : 174.37 (-2.46%)
BURL : 241.31 (-1.83%)
RH : 236.45 (-3.79%)
SQ : 83.49 (-2.58%)
SFE : 9.80 (-1.90%)
VSTO : 9.38 (-0.21%)
RUBI : 12.61 (-3.45%)
CMRX : 1.73 (unch)
Chimerix Presents Updated Results from Phase 2 Clinical Trial of DSTAT in Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia at American Society of Hematology Annual Meeting

Chimerix, Inc. (Nasdaq: CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announced that data relating to its dociparstat...

CMRX : 1.73 (unch)
Stocks Not Happy About Talk of Trade Deal Delay

Stocks Not Happy About Talk of Trade Deal Delay

PTC : 88.62 (+0.27%)
BZUN : 33.18 (+1.84%)
SCVL : 34.96 (-3.93%)
RH : 236.45 (-3.79%)
JEC : 85.84 (+0.96%)
CMRX : 1.73 (unch)
OMI : 6.95 (-2.80%)
RLGY : 13.11 (+0.23%)
QUOT : 9.93 (+1.22%)
Chimerix: 3Q Earnings Snapshot

DURHAM, N.C. (AP) _ Chimerix Inc. (CMRX) on Tuesday reported a loss of $73.7 million in its third quarter.

CMRX : 1.73 (unch)
Chimerix to Present at Upcoming Investor Conferences

Chimerix, Inc. (Nasdaq: CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announced that management will present...

CMRX : 1.73 (unch)
Chimerix to Announce Third Quarter 2019 Financial Results and Provide an Operational Update on November 5, 2019

Chimerix, Inc. (Nasdaq: CMRX), a biopharmaceutical company focused on accelerating the development of innovative medicines to treat patients with cancer and other serious diseases, today announced that...

CMRX : 1.73 (unch)
Chimerix Inc Falls 1.04% on Heavy Volume: Watch For Potential Rebound

Chimerix Inc (NASDAQ:CMRX) traded in a range yesterday that spanned from a low of $1.83 to a high of $1.94. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $1.87...

CMRX : 1.73 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade CMRX with:

Business Summary

Chimerix, Inc. engages in the discovery, development and commercialization of oral antiviral therapeutics for various medical needs. The Company is developing various product candidates for the treatment of dsDNA viruses, HIV, hepatitis C, influenza and smallpox which are under different phases of clinical...

See More

Key Turning Points

2nd Resistance Point 1.81
1st Resistance Point 1.77
Last Price 1.73
1st Support Level 1.69
2nd Support Level 1.65

See More

52-Week High 4.40
Fibonacci 61.8% 3.20
Fibonacci 50% 2.83
Fibonacci 38.2% 2.45
Last Price 1.73
52-Week Low 1.25

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar